Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
FDA panel backs Lumicell’s agent for breast cancer imaging tool
Medtech Dive
Mon, 03/11/24 - 11:56 am
Medtech
Lumicell
breast cancer
imaging
Pfizer funnels $15M into 3-year ACS initiative designed to tackle cancer care disparities
Fierce Biotech
Mon, 02/5/24 - 10:23 am
Pfizer
American Cancer Society
clinical trials
pharma marketing
breast cancer
prostate cancer
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
BioNTech
Duality Biologics
clinical trials
breast cancer
AstraZeneca
Daiichi Sankyo
HER2+ breast cancer
Seagen seeks new approval for Tukysa in HER2+ breast cancer
Clinical Trials Arena
Mon, 12/18/23 - 11:32 am
Seagen
Tukysa
breast cancer
HER2+ breast cancer
Novartis gears up for label expansion for Kisqali with Phase III results
Clinical Trials Arena
Mon, 12/11/23 - 11:18 am
Novartis
Kisqali
FDA
clinical trials
early breast cancer
breast cancer
Roche reports positive Phase III data for breast cancer therapy
Clinical Trials Arena
Tue, 12/5/23 - 09:56 am
Roche
clinical trials
inavolisib
metastatic breast cancer
breast cancer
AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment
BioSpace
Sun, 11/19/23 - 09:36 pm
AstraZeneca
Truqap
breast cancer
FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer
Pharm Exec
Fri, 11/17/23 - 10:09 am
AstraZeneca
Truqap
breast cancer
HR-positive
Olema scores in Phase II breast cancer trial with Phase III dosing in weeks
Clinical Trials Arena
Mon, 10/23/23 - 09:10 am
Olema
clinical tirals
palazestrant
breast cancer
Seagen wins future royalties in Enhertu patent dispute
Pharmaphorum
Wed, 10/18/23 - 10:07 am
Seagen
Daiichi Sankyo
breast cancer
Enhertu
drug royalties
BioNTech takes another leaf out of Daiichi playbook, paying $70M for HER3-directed ADC
Fierce Biotech
Thu, 10/12/23 - 10:07 am
BioNTech
Daiichi Sankyo
antibody-drug conjugate
breast cancer
Daiichi Sankyo reports positive results from trial of breast cancer therapy
Clinical Trials Arena
Mon, 09/25/23 - 11:47 am
Daiichi Sankyo
clinical trials
Dato-DXd
breast cancer
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
BioSpace
Fri, 09/22/23 - 11:51 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Seagen’s breast cancer therapy meets main goal in late-stage study
Medical Marketing and Media
Wed, 08/16/23 - 11:34 pm
Seagen
Tukysa
breast cancer
clinical trials
Merck's Keytruda meets main goal in late-stage breast cancer study
Reuters
Sat, 07/29/23 - 10:40 pm
Merck
Keytruda
clinical trials
breast cancer
ASCO in Review: Oncologists See Practice-Changing, Affirming Data
BioSpace
Thu, 06/8/23 - 09:26 pm
ASCO 2023
oncologists
cancer
AstraZeneca
Tagrisso
non-small cell lung cancer
Novartis
Kisqali
breast cancer
Merck
Keytruda
Moderna Therapeutics
cancer vaccine
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment
BioSpace
Thu, 06/8/23 - 09:50 am
Burning Rock Biotech
genomic profiling
OncoScreen Plus
breast cancer
Medtech
diagnostics
Novartis drug helps stop breast cancer’s return in large study
BioPharma Dive
Fri, 06/2/23 - 11:24 am
Novartis
Kisqali
clinical trials
breast cancer
Byondis' breast cancer drug fails to bloom as FDA denies approval
Fierce Biotech
Tue, 05/16/23 - 10:27 pm
Byondis
antibody-drug conjugate
FDA
breast cancer
HER-2 positive breast cancer
Roche, with HER2 franchise under pressure, pays $70M for breast cancer brain metastases prospect
Fierce Biotech
Tue, 05/9/23 - 11:39 am
Roche
Zion Pharma
brain metastases
breast cancer
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »